271 related articles for article (PubMed ID: 15186431)
1. Hyperplasia of dermal microvascular pericytes in scleroderma.
Helmbold P; Fiedler E; Fischer M; Marsch WCh
J Cutan Pathol; 2004 Jul; 31(6):431-40. PubMed ID: 15186431
[TBL] [Abstract][Full Text] [Related]
2. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
[TBL] [Abstract][Full Text] [Related]
3. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
Ozbilgin MK; Inan S
Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
5. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
[TBL] [Abstract][Full Text] [Related]
6. [3H]Thymidine labeling of dermal endothelial cells in scleroderma.
Fleischmajer R; Perlish JS
J Invest Dermatol; 1977 Oct; 69(4):379-82. PubMed ID: 903666
[TBL] [Abstract][Full Text] [Related]
7. Vascular changes in morphea.
Kobayasi T; Serup J
Acta Derm Venereol; 1985; 65(2):116-20. PubMed ID: 2408412
[TBL] [Abstract][Full Text] [Related]
8. Vascular anomalies in lipoid proteinosis (hyalinosis cutis et mucosae): basement membrane components and ultrastructure.
Mirancea N; Hausser I; Beck R; Metze D; Fusenig NE; Breitkreutz D
J Dermatol Sci; 2006 Jun; 42(3):231-9. PubMed ID: 16497486
[TBL] [Abstract][Full Text] [Related]
9. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma].
Gillery P; Maquart FX; Kalis B; Borel JP
C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006
[TBL] [Abstract][Full Text] [Related]
10. The scleroderma neck sign.
Weinstein CL; Miller MH; Kossard S; Littlejohn GO
J Rheumatol; 1989 Dec; 16(12):1533-5. PubMed ID: 2625682
[TBL] [Abstract][Full Text] [Related]
11. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Hum Pathol; 2006 Feb; 37(2):190-7. PubMed ID: 16426919
[TBL] [Abstract][Full Text] [Related]
12. Reproducible measurements to quantify cutaneous involvement in scleroderma.
Aghassi D; Monoson T; Braverman I
Arch Dermatol; 1995 Oct; 131(10):1160-6. PubMed ID: 7574833
[TBL] [Abstract][Full Text] [Related]
13. [Histological distinction between progressive and circumscript scleroderma].
Ishikawa H; Mori S
Hautarzt; 1972 Sep; 23(9):404-9. PubMed ID: 4264853
[No Abstract] [Full Text] [Related]
14. Isolation and in vitro characterization of human dermal microvascular pericytes.
Helmbold P; Nayak RC; Marsch WC; Herman IM
Microvasc Res; 2001 Mar; 61(2):160-5. PubMed ID: 11254395
[TBL] [Abstract][Full Text] [Related]
15. The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.
Soria A; Cario-André M; Lepreux S; Rezvani HR; Pasquet JM; Pain C; Schaeverbeke T; Mahon FX; Taïeb A
Dermatology; 2008; 216(2):109-17. PubMed ID: 18216472
[TBL] [Abstract][Full Text] [Related]
16. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
[TBL] [Abstract][Full Text] [Related]
17. Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
Wildt M; Hesselstrand R; Akesson A; Scheja A
Scand J Rheumatol; 2007; 36(6):452-7. PubMed ID: 18092267
[TBL] [Abstract][Full Text] [Related]
18. [Lipodermatosclerosis and dermal thickening. A preliminary study].
Blaauw GH; Neumann HA; Berretty PJ
Phlebologie; 1993; 46(1):25-31. PubMed ID: 8327579
[No Abstract] [Full Text] [Related]
19. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
20. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.
Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H
Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
